Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be complicated.

Recent large spenders include Abbvie’s anti-inflammatory drug Skyrizi, which has spent nearly $400 million in linear TV ads this year in the U.S., and Novo Nordisk’s weight-loss drug Wegovy ...

But there’s another downside that’s unlisted, one that’s not associated with the medication but the TV commercial itself: critics say such direct-to-consumer drug ads — which are ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when ...

Not only did AbbVie’s Skyrizi claim first place in the full-year ranking with nearly $377 million spent on 20 separate ads for the drug, according to iSpot.TV’s analysis, but, with two other ...

Currently, it’s legal to market prescription drugs on television ... The prices won’t actually be shown in the TV commercials, but the advertisement will include a website where the list ...

WEDNESDAY, Feb. 12, 2025 (HealthDay News) -- Commercials run by the telehealth company Hims & Hers have been placed under the ...